MPS II: Adaptive behavior of patients and impact on the family system

Journal of Genetic Counseling

Volumn 23, Issue 3, 2014, Pages 330-338

  Needham, Mary ^a   Packman, Wendy ^a   Rappoport, Maxwell ^a   Quinn, Natasha ^a   Cordova, Matthew ^a   Macias, Sandra ^a   Morgan, Cynthia ^b   Packman, Seymour ^b  

^a PALO ALTO UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adaptive behavior; Family impact; Genetic counseling; Hunter Syndrome; MPS II; Psychology

Indexed keywords

ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; CAREGIVER; CHILD; FAMILY; FEMALE; HUMAN; HUNTER SYNDROME; MALE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; CAREGIVERS; CHILD; CHILD, PRESCHOOL; FAMILY; FEMALE; HUMANS; MALE; MUCOPOLYSACCHARIDOSIS II; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84901912289     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-013-9665-4     Document Type: Article

References (15)

1. Bax, M. C.; & Colville, G. A. (1995). Behavior in mucopolysaccharide disorders. Archives of Disease in Childhood, 73, 77-81.
2. Brown, M. B. (1999). The mucopolysaccharidoses. In S. Goldstein & C. R. Reynolds (Eds.), Handbook of Neurodevelopmental and Genetic Disorders in Children (pp. 317-336). New York: The Guilford Press.
3. Bruininks, R. H.; Thurlow, M.; & Gilman, C. J. (1987). Adaptive behavior and mental retardation. Journal of Special Education, 24, 69-88.
4. Cohen, M. S. (1999). Families coping with childhood chronic illness: a research review. Family System Health, 17, 149-164. (Pubitemid 29293731)
5. Food and Drug Administration. (2006). Treatment for Hunter syndrome approved. FDA Consumer, September-October 2006, 4.
6. Froissart, R.; Da Silva, I. M.; & Maire, I. (2007). Mucopolysaccharidosis type II: an update on mutation spectrum. Acta Pædactrica, 96, 71-77. (Pubitemid 46481123)
7. Hsieh, H. F.; & Shannon, S. E. (2005). Three approaches to content analysis. Qualitative Health Research, 15(9), 1277-1288. (Pubitemid 41645161)
8. Martin, R.; Beck, M.; Eng, C.; et al. (2008). Recognition and diagnosis of mucopolysaccharidosis II (Hunter Syndrome). Pediatrics, 121, 377-386. (Pubitemid 351198459)
9. National MPS Society. (2013). MPS II (Hunter syndrome). Retrieved from: http://www.mpssociety.org/mps/mps-ii/
10. Schwartz, I.; Ribeiro, M. G.; Mota, J. G.; et al. (2007). A clinical study of 77 patients with mucopolysaccharidosis type II. Acta Pædactrica, 96, 63-70. (Pubitemid 46481122)
11. Sparrow, S. S.; Cicchetti, D. V.; & Balla, D. A. (2005). Vineland-II vineland adaptive behavior scales (2nd ed.): survey forms manual. Circle Pines: AGS Publishing.
12. Varni, J. W.; Sherman, S. A.; Burwinkle, T. M.; et al. (2004). The PedsQL family impact module: preliminary reliability and validity. Health and Quality of Life Outcomes, 2, 55. (Pubitemid 40472028)
13. Wraith, J. E. (2008). Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type 2. Acta Paedactrica, 97, 76-78. (Pubitemid 351421301)
14. Wraith, J. E.; Scarpa, M.; Beck, M.; et al. (2008). Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. European Journal of Pediatrics, 167, 267.
15. Young, I. D.; & Harper, P. S. (1981). Psychosocial problems in Hunter Syndrome. Child Care Health Development, 7, 201-209.